期刊文献+

COPD纤维支气管镜肺泡灌洗液中可溶性晚期糖基化终末产物受体水平的临床意义 被引量:15

The Clinical Significances of Soluble Receptor for Advanced Glycation Endproducts in Bronchoscopy Alveolus Lavage Fluid among Patients with COPD
下载PDF
导出
摘要 目的探讨纤维支气管镜肺泡灌洗液中可溶性晚期糖基化终末产物受体(sRAGE)水平在COPD中的临床意义。方法选取2012年10月—2013年5月入住辽宁医学院附属第一医院重症监护病房COPD患者40例为COPD组,另选取同时期非COPD组患者40例为非COPD组;将COPD患者分为轻度COPD组(12例)、中度COPD组(10例)、重度COPD组(10例)、极重度COPD组(8例)。采用酶联免疫吸附试验(ELISA)方法检测纤维支气管镜肺泡灌洗液中sRAGE水平。结果 COPD组患者纤维支气管镜肺泡灌洗液sRAGE水平为(191±71)ng/L,高于非COPD组的(55±56)ng/L(t=9.44,P<0.001)。轻度COPD组纤维支气管镜肺泡灌洗液sRAGE水平为(111±44)ng/L、中度COPD组为(184±45)ng/L、重度COPD组为(226±34)ng/L、极重度COPD组为(273±30)ng/L,差异有统计学意义(F=30.48,P<0.001),且极重度COPD组高于重度COPD组,重度COPD组高于中度COPD组,中度COPD组高于轻度COPD组(P<0.05)。直线相关分析结果显示,COPD患者纤维支气管镜肺泡灌洗液sRAGE水平与一秒用力呼气容积占预计值百分比(FEV1%)呈负相关(r=-0.738,P<0.05)。结论 COPD患者纤维支气管镜肺泡灌洗液中sRAGE水平较非COPD患者增高,纤维支气管镜肺泡灌洗液中sRAGE水平与COPD病情严重程度有关,可作为评价COPD预后的一个指标。 Objective To discuss the clinical significances of soluble receptor for advanced glycation end-products ( sRAGE)in bronchoscopy alveolus lavage fluid( BALF)in patients with COPD. Methods A total of 40 patients with COPD who were admitted to the department of intensive care unit of the First Hospital Affiliated to Liaoning Medical University from Oc-tober 2012 to May 2013,were selected as the COPD group,meanwhile 40 patients with non-COPD were selected as the non-COPD group,and these COPD patients were divided into mild group(12 cases),moderate group(10 cases),severe group (10 cases),very severe group(8 cases). The sRAGE concentrations in BALF were detected by enzyme-linked immunosor-bent assay(ELISA). Results The concentration of sRAGE in BALF of patients in the COPD group(191 ±71)ng/L was sig-nificantly higher than that in the non-COPD group(55 ±56)ng/L(t=9. 44,P〈0. 001). The concentration of sRAGE in BALF of COPD patients in the mild group,moderate group,severe group and very severe group was(111 ± 44) ng/L,(184 ±45)ng/L,(226 ±34)ng/L,and(273 ±30)ng/L,respectively,there were significant differences in concentration of sRAGE among these groups(F=30. 48,P〈0. 001),and the concentration of sRAGE in very severe COPD group was signifi-cantly higher than that in severe COPD group,the concentration of sRAGE in severe COPD group was significantly higher than that in moderate group,the concentration of sRAGE in moderate group was significantly higher than that in mild group( P 〈0. 05 ) . Linear correlation analysis results showed that the concentration of sRAGE in BALF of COPD patients were negatively cor-related with FEV1%(r= -0. 738,P 〈0. 05). Conclusion The concentration of sRAGE in BALF of COPD patients was higher than that of non-COPD patients;The concentration of sRAGE in BALF is related to severity of COPD,it could be used as an index of the prognosis evaluation of COPD.
出处 《中国全科医学》 CAS CSCD 北大核心 2014年第24期2802-2805,共4页 Chinese General Practice
基金 辽宁省教育厅科学技术研究项目(2008419)
关键词 肺疾病 慢性阻塞性 支气管肺泡灌洗液 可溶性晚期糖基化终末产物 Pulmonary disease,chronic obstructive Bronchoalveolar lavage fluid Soluble receptor for advanced glycation end-products
  • 相关文献

参考文献18

  • 1van Zoelen MA, Achouiti A, van der Poll T. The role of receptor for ad- vanced glycation endproducts ( RAGE ) in infection [ J ]. Crit Care, 2011, 15 (2): 208.
  • 2Kierdorf K, Fritz G. RAGE regulation and signaling in inflammation and beyond [J]. J Leukoc Biol, 2013, 94 (1): 55-68.
  • 3Mosquera JA. Role of the receptor for advanced glycation end products (RAGE) in inflammation [J]. Invest Clin, 2010, 51 (2): 257- 268.
  • 4Buckley ST, Ehrhardt C. The receptor for advanced glycation end prod- ucts (RAGE) and the Lung [ J]. J Biomed Biotechnol, 2010, 2010: 917108.
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 6王彦霞,杨秀芬,游道峰,石玉珍,苏冠丽,梁欣.慢性阻塞性肺疾病患者血清NO、TNF-α、hs-CRP水平及临床意义的探讨[J].疑难病杂志,2011,10(3):180-182. 被引量:9
  • 7张广梅.慢性阻塞性肺疾病患者血清IL-6、IL-8、高敏C反应蛋白、甲状腺激素水平变化的临床研究[J].实用心脑肺血管病杂志,2012,20(5):791-792. 被引量:18
  • 8Kim JK, Park S, Lee M J, et al. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and preinflammatory ligand for RAGE ( EN - RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis [ J ]. Atherosclerosis, 2012, 220 (1) : 208 -214.
  • 9Demling N, Ehrhardt C, Kasper M, et al. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differen- tiation marker of human alveolar epithelial type I cells [ J]. Cell Tis- sue Res, 2006, 323 (3): 475-488.
  • 10Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble recep- tor for advanced glycation end - products in COPD [J]. Eur Respir J, 2011, 37 (3): 516-522.

二级参考文献89

共引文献8322

同被引文献151

  • 1陆月明,顾秀莲.急性呼吸窘迫综合征研究进展[J].中华流行病学杂志,2005,26(6):463-465. 被引量:16
  • 2安新,张继艳,段建明.盐酸戊乙奎醚雾吸治疗COPD的疗效观察[J].临床肺科杂志,2006,11(6):810-811. 被引量:2
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1794
  • 4吴群,杨红卫.机械通气下经纤支镜灌洗治疗严重肺部感染[J].临床肺科杂志,2007,12(12):1370-1370. 被引量:22
  • 5Zaccard CR,Schell RF,Spiegel CA. Efficacy of bilateral bronchoalveolarlavage for diagnosis of ventilator-associated pneumonia[J]. J Clin Microbiol,2009,47(9):2918-2924.
  • 6Reynolds HY. Bronchoalveolar lavage in interstitial lung disease[J]. CurrOpin Pulm Med,2009 ’15(5) :479-485.
  • 7Fenster BE, Lasalvial, Schroeder JD, et al. Cystatin C: a potential biomarker for pulmonary arterial hypertension [J]. Re- spirology,2014,19(4):583 -589.
  • 8Nitsch D, Grams M, Sang Y, et al. Asso- ciations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis[J]. BMJ, 2013, 346(5):466-472.
  • 9Y T, Y M. Urinary cystatin C as a biomar- ker for diabetic nephropathy and its im- munohistochemical localization in kidney in Zueker diabetic fatty (ZDF) rats[J]. Ex- pToxicolPathol,2013, 65(5):615-622.
  • 10Narsingam S, Bozarth AL, Abdeljalil A. Updates in the management of stable chro- nic obstructive pulmonary disease[J]. Post- grad Med,2014,127(7):758-770.

引证文献15

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部